V

Vifor Pharma AG
SIX:VIFN

Watchlist Manager
Vifor Pharma AG
SIX:VIFN
Watchlist
Price: 166.15 CHF 0.48% Market Closed
Market Cap: 10.8B CHF

Wall Street
Price Targets

VIFN Price Targets Summary
Vifor Pharma AG

There are no price targets for VIFN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Vifor Pharma AG Competitors:
Price Targets
BMY
Bristol-Myers Squibb Co
2% Upside
300357
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
12% Upside
600521
Zhejiang Huahai Pharmaceutical Co Ltd
24% Upside
600750
Jiang Zhong Pharmaceutical Co Ltd
23% Upside
1789
ScinoPharm Taiwan Ltd
27% Upside
MEDCL
Medincell SA
46% Upside
IMP
Imexpharm Corp
3% Upside
AETHER
Aether Industries Ltd
27% Upside

Revenue
Forecast

Revenue Estimate
Vifor Pharma AG

For the last 8 years the compound annual growth rate for Vifor Pharma AG's revenue is -8%. The projected CAGR for the next 3 years is 11%.

-8%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Vifor Pharma AG

For the last 8 years the compound annual growth rate for Vifor Pharma AG's operating income is -1%. The projected CAGR for the next 3 years is 16%.

-1%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Vifor Pharma AG

For the last 8 years the compound annual growth rate for Vifor Pharma AG's net income is -9%. The projected CAGR for the next 3 years is 31%.

-9%
Past Growth
31%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VIFN's stock price target?
Not Available

VIFN doesn't have any price targets made by Wall Street professionals.

What is Vifor Pharma AG's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Vifor Pharma AG's revenue is -8%. The projected CAGR for the next 3 years is 11%.

What is Vifor Pharma AG's Operating Income forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Vifor Pharma AG's operating income is -1%. The projected CAGR for the next 3 years is 16%.

What is Vifor Pharma AG's Net Income forecast?
Projected CAGR
31%

For the last 8 years the compound annual growth rate for Vifor Pharma AG's net income is -9%. The projected CAGR for the next 3 years is 31%.

Back to Top